United States

Showing 201-210 of 351 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
Targeting sub-micron ultrasound contrast agents to the immune-infiltrated islet microenvironment in Type1 diabetes	Regents of the University of Colorado	Richard Benninger	Cures	01-July-2024 to 30-June-2027	$900.000,00
Testing the role of the PI3K-AKT-FOXO1-CXCR4 pathway in the bone marrow selection of anti-insulin B cells in T1D	Regents of the University of Colorado	Roberta Pelanda	Cures	01-November-2023 to 31-October-2027	$826.284,00
Continuous Ketone Monitoring as a Tool to Identify Hyperglycemic Events and Predict Kidney Disease Progression in Individuals with Type 1 Diabetes and Moderate-to-Severe Diabetic Kidney Disease	Regents of the University of Colorado	Sarit Polsky	Improving Lives	01-September-2026 to 31-August-2029	$1.400.119,27
Electrochemiluminescence-based islet autoantibody assays detect the islet autoimmunity earlier and more disease specific than radio-binding assay in the longitudinally followed new-born cohort of TEDDY study	Regents of the University of Colorado	Xiaofan Jia	Cures	01-June-2025 to 31-May-2027	$499.989,00
Modeling immune-islet interactions in a vascularized T1D microphysiological system platform	Regents of the University of California at Irvine	Christopher Hughes	Cures	01-October-2026 to 30-September-2027	$300.000,00
Clinical Validation of a Smart Bolus Calculator Informed by Insulin Sensitivity in Adults and Adolescents with Type 1 Diabetes	Rector & Visitors of the University of Virginia	Chiara Fabris	Improving Lives	01-June-2020 to 30-June-2027	$604.390,26
Pancreatic Islet Transplantation for the Treatment of Type 1 Diabetes: In-Silico Developments to Support Clinical Advancements	Rector & Visitors of the University of Virginia	Chiara Fabris	Cures	01-January-2025 to 31-December-2026	$299.916,19
Augmenting a clinical scaffold for long-term graft implantation	Rector & Visitors of the University of Virginia	Donald Griffin	Cures	01-May-2026 to 30-April-2028	$600.000,00
Dual Beta-cell Regenerative and Immunomodulatory Endogenous Agonist as a Replacement Therapy for Type 1 Diabetes	Rector & Visitors of the University of Virginia	Gordon Laurie	Cures	01-October-2025 to 30-September-2027	$300.000,00
Development of simulation tools to support adaptation of automated insulin delivery algorithms across pregnancies complicated by type 1 diabetes	Rector & Visitors of the University of Virginia	Jacopo Pavan	Improving Lives	01-March-2025 to 28-February-2027	$189.316,00